IS6476A - Efnasambönd sem eru nytsamleg til meðhöndlunar eða forvarnar á sjúkdómi sem á sér stað fyrir milligöngu alfa-2B-adrenóviðtaka - Google Patents

Efnasambönd sem eru nytsamleg til meðhöndlunar eða forvarnar á sjúkdómi sem á sér stað fyrir milligöngu alfa-2B-adrenóviðtaka

Info

Publication number
IS6476A
IS6476A IS6476A IS6476A IS6476A IS 6476 A IS6476 A IS 6476A IS 6476 A IS6476 A IS 6476A IS 6476 A IS6476 A IS 6476A IS 6476 A IS6476 A IS 6476A
Authority
IS
Iceland
Prior art keywords
alpha
prevention
treatment
compounds useful
disease occurring
Prior art date
Application number
IS6476A
Other languages
English (en)
Inventor
Wurster Siegfried
Engström Mia
Huovinen Liisa
Kalliokoski Leila
Kelanne Leila
Savola Eeva-Liisa
Original Assignee
Oy Juvantia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20000303A external-priority patent/FI20000303A0/fi
Application filed by Oy Juvantia Pharma Ltd filed Critical Oy Juvantia Pharma Ltd
Publication of IS6476A publication Critical patent/IS6476A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IS6476A 2000-02-11 2002-07-19 Efnasambönd sem eru nytsamleg til meðhöndlunar eða forvarnar á sjúkdómi sem á sér stað fyrir milligöngu alfa-2B-adrenóviðtaka IS6476A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18202100P 2000-02-11 2000-02-11
FI20000303A FI20000303A0 (fi) 2000-02-14 2000-02-14 Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
PCT/FI2001/000105 WO2001058454A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Publications (1)

Publication Number Publication Date
IS6476A true IS6476A (is) 2002-07-19

Family

ID=26160944

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6476A IS6476A (is) 2000-02-11 2002-07-19 Efnasambönd sem eru nytsamleg til meðhöndlunar eða forvarnar á sjúkdómi sem á sér stað fyrir milligöngu alfa-2B-adrenóviðtaka

Country Status (22)

Country Link
EP (1) EP1253926A1 (is)
JP (1) JP2003522148A (is)
KR (1) KR20020080413A (is)
AU (1) AU780802B2 (is)
BR (1) BR0108221A (is)
CA (1) CA2399421A1 (is)
CZ (1) CZ20022884A3 (is)
EA (1) EA200200846A1 (is)
EE (1) EE200200435A (is)
GE (1) GEP20043356B (is)
HR (1) HRP20020746A2 (is)
HU (1) HUP0300032A3 (is)
IL (1) IL151017A0 (is)
IS (1) IS6476A (is)
MX (1) MXPA02007454A (is)
MY (1) MY133957A (is)
NO (1) NO20023773D0 (is)
NZ (1) NZ520500A (is)
PL (1) PL357872A1 (is)
SK (1) SK11472002A3 (is)
WO (1) WO2001058454A1 (is)
YU (1) YU59102A (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000615A (es) * 2001-07-20 2004-04-20 Juvantia Pharma Ltd Oy Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor.
FI116940B (fi) 2001-07-20 2006-04-13 Juvantia Pharma Ltd Oy Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416432D0 (en) * 1984-06-28 1984-08-01 Wyeth John & Brother Ltd Benzoquinolizines
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US6150389A (en) * 1994-07-11 2000-11-21 Allergan Sales, Inc. Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents

Also Published As

Publication number Publication date
AU780802B2 (en) 2005-04-21
EE200200435A (et) 2003-12-15
HUP0300032A2 (en) 2003-05-28
EA200200846A1 (ru) 2002-12-26
CZ20022884A3 (cs) 2003-02-12
WO2001058454A1 (en) 2001-08-16
GEP20043356B (en) 2004-04-13
EP1253926A1 (en) 2002-11-06
HRP20020746A2 (en) 2004-12-31
BR0108221A (pt) 2003-03-05
HUP0300032A3 (en) 2006-01-30
AU3551001A (en) 2001-08-20
KR20020080413A (ko) 2002-10-23
NZ520500A (en) 2005-01-28
MY133957A (en) 2007-11-30
JP2003522148A (ja) 2003-07-22
YU59102A (sh) 2005-11-28
CA2399421A1 (en) 2001-08-16
SK11472002A3 (sk) 2003-02-04
NO20023773L (no) 2002-08-09
IL151017A0 (en) 2003-02-12
PL357872A1 (en) 2004-07-26
NO20023773D0 (no) 2002-08-09
MXPA02007454A (es) 2004-08-23

Similar Documents

Publication Publication Date Title
IS7095A (is) Arýlamín til meðhöndlunar á ástandi sem tengist GSK-3
IS8586A (is) Oxabispidínefnasambönd sem eru gagnleg til að meðhöndla hjartsláttartruflanir
MXPA03008142A (es) Nuevos compuestos antiinflamatorios de bencimidazol.
IT1319039B1 (it) Apparecchiatura di monitoraggio delle condizioni di un conducente.
NO20022278D0 (no) Utlösningsmekanisme for en nedihullspakning
NO20010939L (no) Diagnostikk basert pa tetrazoliumforbindelser
AR028414A1 (es) Compuestos quimicos
DK1326832T3 (da) Kemiske forbindelser
AR028313A1 (es) Un procedimiento para la produccion de una composicion desodorante o antitranspirante
NO20052158L (no) Fremgangsmate for fremstilling av en benzimidazolforbindelse.
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
NO20041132L (no) Trykkforminsker.
DE50103586D1 (de) Fussheberorthese
EE200200257A (et) Seade tootepaanist eraldatud lameda tootelõigu transportimiseks
IT1320016B1 (it) Procedimento per la fabbricazione di strutture di giunzione a saccheprofonde.
ES1044997Y (es) Dispositivo para el desplazamiento de un cesto de una freidora
IS6476A (is) Efnasambönd sem eru nytsamleg til meðhöndlunar eða forvarnar á sjúkdómi sem á sér stað fyrir milligöngu alfa-2B-adrenóviðtaka
GB2347303B (en) My invention the magmobelt
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
ZA200205835B (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.
FI20002807A0 (fi) Menetelmä alkeenien hydroformyloimiseksi
GB0220046D0 (en) Starfish trap
NO20015890D0 (no) Oppdiftslegeme for en merd
SE0102830D0 (sv) Säkerhetssele till toalettlock